Parallax Volatility Advisers
TNGX icon

Parallax Volatility Advisers’s Tango Therapeutics TNGX Stock Holding History

Parallax Volatility Advisers’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-21,872
Closed -$227K – 3175
2020
Q3 		$227K Buy
+21,872
New +$223K ﹤0.01% 2509

Other funds holding TNGX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Parallax Volatility Advisers's TNGX Position: Q4 2020 in Review

Parallax Volatility Advisers sold out of Tango Therapeutics (TNGX) in Q4 2020, closing a stake of 21,872 shares — an estimated $227K sold.

Parallax Volatility Advisers first reported a position in TNGX in Q3 2020 and held it in 1 quarter. The position peaked at $227K in Q3 2020. 39 funds tracked by Wall St. Rank hold TNGX as of Q4 2020.

  • Parallax Volatility Advisers reported no remaining Tango Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Parallax Volatility Advisers sold 21,872 Tango Therapeutics shares in Q4 2020, an estimated $227K.
  • Parallax Volatility Advisers first reported a position in Tango Therapeutics in Q3 2020 and held it in 1 quarter.
  • Parallax Volatility Advisers's Tango Therapeutics position peaked at $227K in Q3 2020.
  • 39 funds tracked by Wall St. Rank held Tango Therapeutics as of Q4 2020.

Based on Parallax Volatility Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.